Promoting smoking cessation

American Family Physician

Volumn 85, Issue 6, 2012, Pages 591-598

  Larzelere, Michele M ^a   Williams, Dave E ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU Family Practice Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; NICOTINIC RECEPTOR; NORTRIPTYLINE; NOSE SPRAY; VARENICLINE;

ACUPUNCTURE; AGE; ARTICLE; BEHAVIOR CHANGE; BIRTH DEFECT; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; COUGHING; DREAM; DRUG DOSE INCREASE; EXERCISE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEARTBURN; HUMAN; INSOMNIA; ISCHEMIC HEART DISEASE; MOTIVATION; NAUSEA; NICOTINE REPLACEMENT THERAPY; NOSE IRRITATION; PATIENT COUNSELING; PHYSICIAN; PREGNANT WOMAN; RECOMMENDED DRUG DOSE; RHINITIS; RISK FACTOR; SIDE EFFECT; SKIN MANIFESTATION; SMOKING CESSATION; THROAT IRRITATION; TOBACCO; UNSTABLE ANGINA PECTORIS; XEROSTOMIA;

EID: 84859115633     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226-1228.
2. Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2009. Vital Health Stat 10. 2010;(249):1-207.
3. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233-239.
4. Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Rockville Md.: Public Health Service; 2008. http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf. Accessed March 12, 2011.
5. American Academy of Family Physicians. AAFP policies. Tobacco use, prevention, and cessation. http://www.aafp.org/online/en/home/policy/policies/t/tobacco.html. Accessed August 2, 2011.
6. U.S. Preventive Services Task Force. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150(8):551-555.
7. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001007
8. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001292
9. Solberg LI, Boyle RG, Davidson G, Magnan SJ, Carlson CL. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clin Proc. 2001;76(2):138-143.
10. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;(2):CD000165.
11. Lindson N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2010;(3):CD008033.
12. Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict. 2005;14(2):106-123.
13. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264(12):1546-1549.
14. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357(9272):1929-1932.
15. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med. 1991;324(11):739-745.
16. University of Michigan Health System. Clinical care guidelines. Smoking cessation. August 2006. http://www.med.umich.edu/1info/fhp/practiceguides/smoking.html. Accessed March 23, 2011.
17. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007;64(18):1917-1921.
18. Meyer JM. Individual changes in clozapine levels after smoking cessation: results and a predictive model. J Clin Psychopharmacol. 2001;21(6):569-574.
19. Swanson JA, Lee JW, Hopp JW, Berk LS. The impact of caffeine use on tobacco cessation and withdrawal. Addict Behav. 1997;22(1):55-68.
20. Rothemich SF, Woolf SH, Johnson RE, et al. Effect on cessation counseling of documenting smoking status as a routine vital sign: An ACORN study. Ann Fam Med. 2008;6(1):60-68.
21. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;(2):CD000165.
22. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. New York, NY: Guilford Press; 2002.
23. Prochaska JO, Norcross JC. Stages of change. Psychotherapy. 2001;38(4):443-448.
24. Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010;(11):CD004492.
25. Lai DT, Cahill K, Qin Y, Tang JL. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2010;(1):CD006936.
26. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598-600.
27. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146.
28. Coe JW, Brooks PR, Vetelino MG, et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48(10):3474-3477.
29. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD000031.
30. U.S. Food and Drug Administration. FDA drug safety communication: Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease. June 16, 2011. http://www.fda.gov/Drugs/DrugSafety/ucm259161.htm. Accessed August 2, 2011.
31. Oncken C, Gonzales D, Nides M, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med. 2006;166(15):1571-1577.
32. Gonzales D, Rennard SI, Nides M, et al.; Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47-55.
33. White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2011;(1):CD000009.
34. Ussher MH, Taylor A, Faulkner G. Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2008;(4):CD002295.
35. Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2009;(1):CD006219.
36. Barnes J, Dong CY, McRobbie H, Walker N, Mehta M, Stead LF. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2010;(10):CD001008.
37. Civljak M, Sheikh A, Stead LF, Car J. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010;(9):CD007078.
38. Borland R, Balmford J, Bishop N, et al. In-practice management versus quitline referral for enhancing smoking cessation in general practice: a cluster randomized trial. Fam Pract. 2008;25(5):382-389.
39. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006;(3):CD002850.
40. Morales-Suárez-Varela MM, Bille C, Christensen K, Olsen J. Smoking habits, nicotine use, and congenital malformations. Obstet Gynecol. 2006;107(1):51-57.
41. Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J. 2003;24(10):946-955.
42. Curry SC, Kashani JS, LoVecchio F, Holubek W. Intraventricular conduction delay after bupropion overdose. J Emerg Med. 2005;29(3):299-305.
43. McNeill A, Foulds J, Bates C. Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction. 2001;96(12):1757-1768.
44. Centers for Disease Control and Prevention. Cigarette use among high school students-United States, 1991-2005. MMWR Morb Mortal Wkly Rep. 2006;55(26):724-726.
45. U.S. Preventive Services Task Force. Counseling to prevent tobacco use and tobacco-caused disease. Recommendation statement. November 2003. http://www.uspreventiveservicestaskforce.org/3rduspstf/tobacccoun/tobcounrs.htm. Accessed December 7, 2011.
46. Moolchan ET, Robinson ML, Ernst M, et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics. 2005;115(4):e407-e414.